Trial Profile
Phase 1, Open-Label, Safety and Pharmacokinetic Study to Assess Bronchopulmonary Disposition of Intravenous TP-434 in Healthy Men and Women
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Dec 2021
Price :
$35
*
At a glance
- Drugs Eravacycline (Primary)
- Indications Intra-abdominal infections; Respiratory tract infections; Urinary tract infections
- Focus Pharmacokinetics
- Acronyms BAL
- Sponsors Tetraphase Pharmaceuticals
- 27 Nov 2013 New trial record